J Jacob

723 total citations
19 papers, 557 citations indexed

About

J Jacob is a scholar working on Oncology, Immunology and Reproductive Medicine. According to data from OpenAlex, J Jacob has authored 19 papers receiving a total of 557 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 7 papers in Immunology and 5 papers in Reproductive Medicine. Recurrent topics in J Jacob's work include Ovarian cancer diagnosis and treatment (5 papers), Viral-associated cancers and disorders (5 papers) and T-cell and Retrovirus Studies (3 papers). J Jacob is often cited by papers focused on Ovarian cancer diagnosis and treatment (5 papers), Viral-associated cancers and disorders (5 papers) and T-cell and Retrovirus Studies (3 papers). J Jacob collaborates with scholars based in United States, Malaysia and Thailand. J Jacob's co-authors include Elise C. Kohn, E Reed, Gisele Sarosy, Edward P. Gelmann, Henry Masur, Olivia T. Preble, Debra O. Adamo, M.L. Rothenberg, Anthony S. Fauci and Robert E. Cunnion and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Annals of the New York Academy of Sciences.

In The Last Decade

J Jacob

17 papers receiving 516 citations

Peers

J Jacob
Philippe C. Bishop United States
Elisabeth Ludwig Germany
R L Wolfert United States
Amu Therwath France
K Yasukawa Japan
Neru Munshi United States
Gonzalo Rubio Spain
Charles S. Hesdorffer United States
Peter Moosmann Switzerland
Andrew Shih United States
Philippe C. Bishop United States
J Jacob
Citations per year, relative to J Jacob J Jacob (= 1×) peers Philippe C. Bishop

Countries citing papers authored by J Jacob

Since Specialization
Citations

This map shows the geographic impact of J Jacob's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Jacob with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Jacob more than expected).

Fields of papers citing papers by J Jacob

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Jacob. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Jacob. The network helps show where J Jacob may publish in the future.

Co-authorship network of co-authors of J Jacob

This figure shows the co-authorship network connecting the top 25 collaborators of J Jacob. A scholar is included among the top collaborators of J Jacob based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Jacob. J Jacob is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Bicher, Annette, Gisele Sarosy, Elise C. Kohn, et al.. (2010). Age does not influence taxol dose intensity in recurrent carcinoma of the ovary. Cancer. 71(S2). 594–600. 5 indexed citations
2.
Reed, Eddie, Gisele Sarosy, Elise C. Kohn, et al.. (1996). A Phase I Study of Paclitaxel and Cyclophosphamide in Recurrent Adenocarcinoma of the Ovary. Gynecologic Oncology. 61(3). 349–353. 4 indexed citations
3.
Kohn, Elise C., E Reed, Gisele Sarosy, et al.. (1996). Clinical investigation of a cytostatic calcium influx inhibitor in patients with refractory cancers.. PubMed. 56(3). 569–73. 94 indexed citations
4.
Bicher, Annette, Elise C. Kohn, Gisele Sarosy, et al.. (1993). The absence of cumulative bone marrow toxicity in patients with recurrent adenocarcinoma of the ovary receiving dose-intense taxol and granulocyte colony stimulating factor. Anti-Cancer Drugs. 4(2). 141–148. 8 indexed citations
5.
Reed, E, John E. Janik, M. A. Bookman, et al.. (1993). High-dose carboplatin and recombinant granulocyte-macrophage colony-stimulating factor in advanced-stage recurrent ovarian cancer.. Journal of Clinical Oncology. 11(11). 2118–2126. 18 indexed citations
6.
Dawson, Nancy A., George Wilding, D. G. McLeod, et al.. (1992). A pilot trial of chemohormonal therapy for metastatic prostate carcinoma. Cancer. 69(1). 213–218. 13 indexed citations
7.
Sarosy, Gisele, Elise C. Kohn, David A. Stone, et al.. (1992). Phase I study of taxol and granulocyte colony-stimulating factor in patients with refractory ovarian cancer.. Journal of Clinical Oncology. 10(7). 1165–1170. 163 indexed citations
8.
Reed, Eddie, J Jacob, R F Ozols, Robert C. Young, & Carmen J. Allegra. (1992). 5-fluorouracil (5-FU) and leucovorin in platinum-refractory advanced stage ovarian carcinoma. Gynecologic Oncology. 46(3). 326–329. 8 indexed citations
9.
Reed, E, J Jacob, & Otis W. Brawley. (1991). Measures of renal function in patients with cisplatin-related chronic renal disease.. PubMed. 83(6). 522–6. 5 indexed citations
10.
Grady, Christine, J Jacob, & Carol A. Romano. (1991). Confidentiality: A Survey in a Research Hospital. The Journal of Clinical Ethics. 2(1). 25–30. 7 indexed citations
11.
Jacob, J, et al.. (1989). Assessment tool for nurses' learning needs and priorities relative to caring for patients with AIDS and Kaposi's sarcoma. Seminars in Oncology Nursing. 5(4). 308–312. 1 indexed citations
12.
Jacob, J, Barbara Baird, Susan Haller, & Yechiam Ostchega. (1989). AIDS-related Kaposi's sarcoma: Concepts of care. Seminars in Oncology Nursing. 5(4). 263–275. 1 indexed citations
13.
Gelmann, Edward P., Dan L. Longo, H. Clifford Lane, et al.. (1987). Combination chemotherapy of disseminated kaposi's sarcoma in patients with the acquired immune deficiency syndrome. The American Journal of Medicine. 82(3). 456–462. 57 indexed citations
14.
Frederick, Winston, Jay S. Epstein, Edward P. Gelmann, et al.. (1985). Viral Infections and Cell-Mediated Immunity in Immunodeficient Homosexual Men with Kaposi's Sarcoma Treated with Human Lymphoblastoid Interferon. The Journal of Infectious Diseases. 152(1). 162–170. 13 indexed citations
15.
16.
Gelmann, Edward P., Olivia T. Preble, Ronald G. Steis, et al.. (1985). Human lymphoblastoid interferon treatment of Kaposi's sarcoma in the acquired immune deficiency syndrome. Clinical response and prognostic parameters. The American Journal of Medicine. 78(5). 737–741. 86 indexed citations
17.
Kleinerman, Eugenie S., et al.. (1985). Activation of monocyte-mediated tumoricidal activity in patients with acquired immunodeficiency syndrome.. Journal of Clinical Oncology. 3(7). 1005–1012. 8 indexed citations
18.
Longo, Dan L., Ronald G. Steis, H. Clifford Lane, et al.. (1984). MALIGNANCIES IN THE AIDS PATIENT: NATURAL HISTORY, TREATMENT STRATEGIES, AND PRELIMINARY RESULTS. Annals of the New York Academy of Sciences. 437(1). 421–430. 39 indexed citations
19.
Jacob, J, et al.. (1977). Documenting patient care in the OR. AORN Journal. 26(4). 659–663. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Philippe C. Bishop Breakdown of academic impact, for papers by Elisabeth Ludwig Breakdown of academic impact, for papers by R L Wolfert Breakdown of academic impact, for papers by Amu Therwath Breakdown of academic impact, for papers by K Yasukawa Breakdown of academic impact, for papers by Neru Munshi Breakdown of academic impact, for papers by Gonzalo Rubio Breakdown of academic impact, for papers by Charles S. Hesdorffer Breakdown of academic impact, for papers by Peter Moosmann Breakdown of academic impact, for papers by Andrew Shih
Rankless by CCL
2026